Literature DB >> 11966507

Extra-intestinal manifestations associated with irritable bowel syndrome: a twin study.

P Svedberg1, S Johansson, M-A Wallander, B Hamelin, N L Pedersen.   

Abstract

BACKGROUND: Little is known about the role of genetic and environmental factors in irritable bowel syndrome. Various extra-intestinal manifestations are more prevalent in cases than in controls. Genetic effects may be important in the liability to develop functional bowel disorders. AIMS: To evaluate the associations of irritable bowel syndrome with several disorders co-morbid with the condition, using both a case-control design and a co-twin control design.
METHODS: A sample of 850 Swedish twin pairs, aged 18-85 years, was contacted for a telephone interview. Through a diagnostic algorithm, 72 unrelated cases of irritable bowel syndrome and 216 age- and gender-matched controls were identified. Fifty-eight twin pairs discordant for irritable bowel syndrome were evaluated in co-twin analyses.
RESULTS: Renal problems (odds ratio (OR)=3.3; confidence interval (CI), 1.3-8.2), obesity (OR=2.6; CI, 1.0-6.4), underweight in the past (OR=2.4; CI, 1.1-6.4), gluten intolerance (OR=9.0; CI, 1.4-60.1), rheumatoid arthritis (OR=3.2; CI, 1.1-9.4) and poor self-rated health (OR=1.8; CI, 1.0-3.2) were significantly associated with irritable bowel syndrome. In the co-twin analyses, the only factors maintaining significance were renal and recurrent urinary tract problems.
CONCLUSIONS: The association between irritable bowel syndrome and renal and urinary tract problems does not reflect a genetic or familial mediation. Eating disorders in childhood represent a familial-environmental influence on irritable bowel syndrome, whereas the association with rheumatoid arthritis and perhaps gluten intolerance probably reflects genetic mediation.

Entities:  

Mesh:

Year:  2002        PMID: 11966507     DOI: 10.1046/j.1365-2036.2002.01254.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  17 in total

1.  Obesity and irritable bowel syndrome: a comprehensive review.

Authors:  Octavia Pickett-Blakely
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-07

2.  A population-based twin study of functional somatic syndromes.

Authors:  K Kato; P F Sullivan; B Evengård; N L Pedersen
Journal:  Psychol Med       Date:  2008-06-26       Impact factor: 7.723

3.  Visceral abdominal obesity is associated with an increased risk of irritable bowel syndrome.

Authors:  Chang Geun Lee; Jun Kyu Lee; Yun-Seong Kang; Seungmin Shin; Jae Hak Kim; Yun Jeong Lim; Moon-Soo Koh; Jin Ho Lee; Hyoun Woo Kang
Journal:  Am J Gastroenterol       Date:  2015-01-13       Impact factor: 10.864

4.  The relationship between obesity and functional gastrointestinal disorders: causation, association, or neither?

Authors:  Wayne Ho; Brennan M R Spiegel
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-08

5.  Latent class analysis of functional somatic symptoms in a population-based sample of twins.

Authors:  Kenji Kato; Patrick F Sullivan; Nancy L Pedersen
Journal:  J Psychosom Res       Date:  2010-03-01       Impact factor: 3.006

Review 6.  Abdominal pain after gastric bypass: suspects and solutions.

Authors:  Alexander J Greenstein; Robert W O'Rourke
Journal:  Am J Surg       Date:  2011-02-18       Impact factor: 2.565

Review 7.  The role of genetics in IBS.

Authors:  Yuri A Saito
Journal:  Gastroenterol Clin North Am       Date:  2011-03       Impact factor: 3.806

Review 8.  Chronic functional bowel syndrome enhances gut-brain axis dysfunction, neuroinflammation, cognitive impairment, and vulnerability to dementia.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2014-03-04       Impact factor: 3.996

Review 9.  Genetic epidemiology of irritable bowel syndrome.

Authors:  Jasbir Makker; Sridhar Chilimuri; Jonathan N Bella
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

10.  Binge eating, body mass index, and gastrointestinal symptoms.

Authors:  Christine M Peat; Lu Huang; Laura M Thornton; Ann F Von Holle; Sara E Trace; Paul Lichtenstein; Nancy L Pedersen; D Wayne Overby; Cynthia M Bulik
Journal:  J Psychosom Res       Date:  2013-08-27       Impact factor: 3.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.